Matthew Barth

Research Assistant Professor

University at Buffalo State University of New York School of Medicine and Biomedical Sciences

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Matthew Barth is a Research Assistant Professor at the University at Buffalo State University of New York School of Medicine and Biomedical Sciences. His research interests focus on pediatric oncology, particularly the molecular evolution of lymphomas and the analysis of tumor mutational burden in pediatric patients. Recent publications include studies on aggressive B-cell lymphomas and genomic sequencing in pediatric solid tumors, contributing significantly to the understanding of these complex malignancies.

Articles (16)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (6)

Melinda Pauly

Assistant Professor

Emory University

UNITED STATES

View details

Ajay Gupta

Assistant Professor

Roswell Park Comprehensive Cancer Center

UNITED STATES

View details

Wilian Cortopassi

UNITED STATES

View details

Robert Hayashi

Professor

Washington University in Saint Louis School of Medicine

UNITED STATES

View details

Yana Pikman

Harvard University

UNITED STATES

View details

Francesco Maura

Assistant Professor

Sylvester Comprehensive Cancer Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Matthew Barth

Research Interests

Explore related searches

Contact this professor

About

Articles (16)

An institutional review of genomic sequencing in pediatric solid tumors

Molecular Evolution of Classic Hodgkin Lymphoma Revealed Through Whole-Genome Sequencing of Hodgkin and Reed Sternberg Cells

AMG176, an MCL-1 inhibitor, is active in pre-clinical models of aggressive B-cell lymphomas

Multi-institution analysis of tumor mutational burden and outcomes in pediatric central nervous system tumor patients

Pediatric Aggressive Mature B-Cell Lymphomas, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.

A genetically distinct pediatric subtype of primary CNS large B-cell lymphoma is associated with favorable clinical outcome

MULTI-INSTITUTION ANALYSIS OF TUMOR MUTATIONAL BURDEN AND OUTCOMES IN PEDIATRIC CNS TUMOR PATIENTS

Multi-institution analysis of tumor mutational burden and outcomes in pediatric central nervous system tumor patients

Successful Bone Marrow Transplantation With Intensive Post-transplant Intrathecal Chemotherapy for CNS Relapsed AML in 2 Infants

A genetically distinct pediatric subtype of primary CNS large B-cell lymphoma is associated with favorable clinical outcome

Matched Targeted Therapy for Pediatric Patients with Relapsed, Refractory, or High-Risk Leukemias: A Report from the LEAP Consortium

A dose substitution of anthracycline intensity with dose-dense rituximab in children and adolescents with good-risk mature B-cell lymphoma

Anaplastic lymphoma kinase inhibitor therapy in the treatment of inflammatory myofibroblastic tumors in pediatric patients: Case reports and literature review

Molecular Evolution of Classical Hodgkin Lymphoma Revealed Though Whole Genome Sequencing of Hodgkin and Reed-Sternberg Cells

Final Report of Reduced Anthracycline Dose Intensity with the Addition of Dose Dense Rituximab in Children, Adolescents and Young Adults with De Novo Good Risk Mature B-Cell Non Hodgkin Lymphoma (B-NHL)

Novel Therapies Potentially Available for Pediatric B-Cell Non-Hodgkin Lymphoma

Collaborators (6)

Melinda Pauly

Ajay Gupta

Wilian Cortopassi

Robert Hayashi

Yana Pikman

Francesco Maura

Make your next move.